GlassScriptPhysician profile
Farbod Rastegar
NPI 1871884437
$32,033.12
in general payments reported to CMS, 2019-2025
22 companies · $3,884 in 2025
The $3,884 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,697 · 2020: $237 · 2021: $3,103 · 2022: $3,146 · 2023: $7,954 · 2024: $7,012 · 2025: $3,884.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $16K · Food and Beverage: $2,924 · Entertainment: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $15,660.53 |
| Food and Beverage | $2,924.35 |
| Entertainment | $265.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $8,385.21 | 2019-2025 | Excelsius Gps, Creo, Rise |
| Zavation Medical Products, LLC | $4,846.31 | 2023-2024 | |
| Medtronic, INC. | $3,941.34 | 2021-2024 | Unid_pass |
| Abbott Laboratories | $3,065.68 | 2022-2024 | Proclaim, Eterna |
| Alphatec Spine, INC | $2,545.67 | 2021-2022 | |
| Stryker Corporation | $1,941.32 | 2019-2020 | |
| Aesculap Implant Systems, LLC | $1,735.86 | 2023 | Activl |
| Corelink, LLC | $1,701.80 | 2023 | |
| Medical Device Business Services, INC. | $908.63 | 2019 | |
| Blue Surgical LLC | $755.32 | 2024 | |
| Arthrex, INC. | $686.98 | 2024 | |
| Si-Bone, INC. | $581.22 | 2019-2024 | |
| Nuvasive, INC. | $364.46 | 2019-2021 | |
| Depuy Synthes Sales INC. | $259.47 | 2019-2024 | Expedium Verse, Vivigen Mis Delivery System |
| Medtronic USA, INC. | $145.10 | 2019-2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $74.48 | 2019 | |
| Boston Scientific Corporation | $17.91 | 2025 | Intracept |
| Pacira Pharmaceuticals Incorporated | $17.53 | 2025 | Exparel |
| Novo Nordisk INC | $16.16 | 2024 | Wegovy |
| Solventum Corporation | $14.58 | 2025 | Prevena, V.A.C.Ulta |
| Spinal Elements, INC. | $14.07 | 2019 | |
| Davol INC. | $14.02 | 2025 | Arista |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farbod Rastegar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.